XML 14 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenues        
Consulting Services $ 53,277 $ 71,000 $ 254,669 $ 426,613
Product & Equipment 292,709 197,709 730,198 832,391
Cannabis Products 406,967 714,043
Total Revenues 752,953 268,709 1,698,910 1,259,004
Cost of Revenues        
Cost of Consulting Services 9,473 24,425 36,179 138,980
Cost of Products and Equipment 182,795 133,036 513,051 556,645
Cost of Cannabis Products 231,964 379,753
Total Cost of Revenues 424,232 157,461 928,983 695,625
Gross Profit 328,721 111,248 769,927 563,379
Operating Expenses        
General and Administrative 539,340 195,864 1,428,092 768,499
Selling and Marketing 42,455 85,074 150,301 248,102
Stock Based Compensation Expense 8,318 37,008 12,300
Total Operating Expenses 590,113 280,938 1,615,401 1,028,901
Loss from Operations (261,392) (169,690) (845,474) (465,522)
Other Income (Expense)        
Interest (expense) (28,027) (1,788) (46,837) (2,865)
Debt Forgiveness 130,186 240,100
Other income 938 36,900 3,367 54,499
Total Other Income (Expense) 103,097 35,112 196,630 51,634
Net Loss (158,295) (134,578) (648,844) (413,888)
Income Tax Expense
NET LOSS $ (158,295) $ (134,578) $ (648,844) $ (413,888)
Basic net loss per common share $ (0) $ (0) $ (0) $ (0.01)
Basic and diluted weighted average common shares outstanding 80,052,395 56,500,827 77,584,074 54,477,280